nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Fibrosis—Hydroxyurea—head and neck cancer	0.0343	0.0477	CcSEcCtD
Etonogestrel—Fibrosis—Fluorouracil—head and neck cancer	0.0247	0.0343	CcSEcCtD
Etonogestrel—Breast cancer—Docetaxel—head and neck cancer	0.014	0.0194	CcSEcCtD
Etonogestrel—PGR—Nuclear Receptors—RARB—head and neck cancer	0.0131	0.0467	CbGpPWpGaD
Etonogestrel—Local reaction—Fluorouracil—head and neck cancer	0.0127	0.0177	CcSEcCtD
Etonogestrel—PGR—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.0117	0.0416	CbGpPWpGaD
Etonogestrel—Bone pain—Vinblastine—head and neck cancer	0.0112	0.0156	CcSEcCtD
Etonogestrel—Amenorrhoea—Hydroxyurea—head and neck cancer	0.0112	0.0155	CcSEcCtD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0104	0.0369	CbGpPWpGaD
Etonogestrel—Neoplasm—Vinblastine—head and neck cancer	0.00972	0.0135	CcSEcCtD
Etonogestrel—ESR1—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00931	0.0331	CbGpPWpGaD
Etonogestrel—Menstruation irregular—Docetaxel—head and neck cancer	0.0092	0.0128	CcSEcCtD
Etonogestrel—Foetor hepaticus—Docetaxel—head and neck cancer	0.00897	0.0125	CcSEcCtD
Etonogestrel—Neoplasm—Hydroxyurea—head and neck cancer	0.00886	0.0123	CcSEcCtD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00863	0.0307	CbGpPWpGaD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.00821	0.0292	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—RARB—head and neck cancer	0.00771	0.0274	CbGpPWpGaD
Etonogestrel—Herpes simplex—Fluorouracil—head and neck cancer	0.00765	0.0107	CcSEcCtD
Etonogestrel—Redness—Docetaxel—head and neck cancer	0.00754	0.0105	CcSEcCtD
Etonogestrel—Liver disorder—Docetaxel—head and neck cancer	0.00747	0.0104	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—XRCC1—head and neck cancer	0.00746	0.0265	CbGpPWpGaD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00713	0.0253	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear signaling by ERBB4—YAP1—head and neck cancer	0.00687	0.0244	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—TGFA—head and neck cancer	0.00662	0.0235	CbGpPWpGaD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00659	0.0234	CbGpPWpGaD
Etonogestrel—Otitis media—Docetaxel—head and neck cancer	0.00654	0.0091	CcSEcCtD
Etonogestrel—Breast disorder—Hydroxyurea—head and neck cancer	0.00643	0.00895	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.00609	0.0217	CbGpPWpGaD
Etonogestrel—Depression—Vinblastine—head and neck cancer	0.00599	0.00834	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00589	0.0082	CcSEcCtD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00582	0.0207	CbGpPWpGaD
Etonogestrel—Swelling—Fluorouracil—head and neck cancer	0.0058	0.00808	CcSEcCtD
Etonogestrel—Amenorrhoea—Docetaxel—head and neck cancer	0.00579	0.00806	CcSEcCtD
Etonogestrel—Dysuria—Hydroxyurea—head and neck cancer	0.00575	0.008	CcSEcCtD
Etonogestrel—Weight increased—Hydroxyurea—head and neck cancer	0.0056	0.00779	CcSEcCtD
Etonogestrel—Infestation NOS—Hydroxyurea—head and neck cancer	0.00548	0.00763	CcSEcCtD
Etonogestrel—Infestation—Hydroxyurea—head and neck cancer	0.00548	0.00763	CcSEcCtD
Etonogestrel—Haemoglobin—Vinblastine—head and neck cancer	0.00542	0.00755	CcSEcCtD
Etonogestrel—Haemorrhage—Vinblastine—head and neck cancer	0.0054	0.00751	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00537	0.00748	CcSEcCtD
Etonogestrel—Hypoaesthesia—Vinblastine—head and neck cancer	0.00537	0.00747	CcSEcCtD
Etonogestrel—Pharyngitis—Vinblastine—head and neck cancer	0.00536	0.00745	CcSEcCtD
Etonogestrel—Bone pain—Docetaxel—head and neck cancer	0.00531	0.0074	CcSEcCtD
Etonogestrel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00525	0.0187	CbGpPWpGaD
Etonogestrel—Blood pressure increased—Docetaxel—head and neck cancer	0.00509	0.00709	CcSEcCtD
Etonogestrel—Hepatocellular injury—Docetaxel—head and neck cancer	0.00509	0.00709	CcSEcCtD
Etonogestrel—Injection site reaction—Docetaxel—head and neck cancer	0.00506	0.00704	CcSEcCtD
Etonogestrel—Haemoglobin—Hydroxyurea—head and neck cancer	0.00495	0.00688	CcSEcCtD
Etonogestrel—Influenza like illness—Docetaxel—head and neck cancer	0.00494	0.00688	CcSEcCtD
Etonogestrel—Haemorrhage—Hydroxyurea—head and neck cancer	0.00492	0.00685	CcSEcCtD
Etonogestrel—Irritability—Fluorouracil—head and neck cancer	0.00489	0.0068	CcSEcCtD
Etonogestrel—Fluid retention—Docetaxel—head and neck cancer	0.00483	0.00673	CcSEcCtD
Etonogestrel—Alopecia—Vinblastine—head and neck cancer	0.00477	0.00664	CcSEcCtD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—MAPK3—head and neck cancer	0.00461	0.0164	CbGpPWpGaD
Etonogestrel—Neoplasm—Docetaxel—head and neck cancer	0.0046	0.00641	CcSEcCtD
Etonogestrel—Angiopathy—Hydroxyurea—head and neck cancer	0.00447	0.00621	CcSEcCtD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—MAPK1—head and neck cancer	0.00439	0.0156	CbGpPWpGaD
Etonogestrel—Ill-defined disorder—Vinblastine—head and neck cancer	0.00436	0.00607	CcSEcCtD
Etonogestrel—Alopecia—Hydroxyurea—head and neck cancer	0.00435	0.00605	CcSEcCtD
Etonogestrel—ESR1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00432	0.0153	CbGpPWpGaD
Etonogestrel—Erythema—Hydroxyurea—head and neck cancer	0.00428	0.00596	CcSEcCtD
Etonogestrel—Malaise—Vinblastine—head and neck cancer	0.00424	0.0059	CcSEcCtD
Etonogestrel—Swelling—Docetaxel—head and neck cancer	0.00419	0.00583	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00411	0.00572	CcSEcCtD
Etonogestrel—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00407	0.0145	CbGpPWpGaD
Etonogestrel—Convulsion—Vinblastine—head and neck cancer	0.00407	0.00566	CcSEcCtD
Etonogestrel—Hypertension—Vinblastine—head and neck cancer	0.00406	0.00564	CcSEcCtD
Etonogestrel—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00397	0.00553	CcSEcCtD
Etonogestrel—Discomfort—Vinblastine—head and neck cancer	0.00395	0.0055	CcSEcCtD
Etonogestrel—Hot flush—Docetaxel—head and neck cancer	0.00395	0.0055	CcSEcCtD
Etonogestrel—Infestation NOS—Fluorouracil—head and neck cancer	0.00395	0.00549	CcSEcCtD
Etonogestrel—Infestation—Fluorouracil—head and neck cancer	0.00395	0.00549	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—YAP1—head and neck cancer	0.00394	0.014	CbGpPWpGaD
Etonogestrel—Menopausal symptoms—Docetaxel—head and neck cancer	0.00392	0.00545	CcSEcCtD
Etonogestrel—Visual disturbance—Docetaxel—head and neck cancer	0.0039	0.00543	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00387	0.00538	CcSEcCtD
Etonogestrel—Malaise—Hydroxyurea—head and neck cancer	0.00386	0.00538	CcSEcCtD
Etonogestrel—Urinary tract infection—Fluorouracil—head and neck cancer	0.00384	0.00534	CcSEcCtD
Etonogestrel—Convulsion—Hydroxyurea—head and neck cancer	0.00371	0.00517	CcSEcCtD
Etonogestrel—Sinusitis—Fluorouracil—head and neck cancer	0.0037	0.00515	CcSEcCtD
Etonogestrel—Pain in extremity—Docetaxel—head and neck cancer	0.0037	0.00514	CcSEcCtD
Etonogestrel—ESR1—Estrogen signaling pathway—BCL2—head and neck cancer	0.00369	0.0131	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00369	0.0131	CbGpPWpGaD
Etonogestrel—Anorexia—Vinblastine—head and neck cancer	0.00365	0.00509	CcSEcCtD
Etonogestrel—Migraine—Docetaxel—head and neck cancer	0.00364	0.00506	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00362	0.00504	CcSEcCtD
Etonogestrel—Discomfort—Hydroxyurea—head and neck cancer	0.0036	0.00501	CcSEcCtD
Etonogestrel—Haemoglobin—Fluorouracil—head and neck cancer	0.00356	0.00495	CcSEcCtD
Etonogestrel—Rhinitis—Fluorouracil—head and neck cancer	0.00355	0.00494	CcSEcCtD
Etonogestrel—Haemorrhage—Fluorouracil—head and neck cancer	0.00354	0.00493	CcSEcCtD
Etonogestrel—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00352	0.0049	CcSEcCtD
Etonogestrel—Pharyngitis—Fluorouracil—head and neck cancer	0.00352	0.00489	CcSEcCtD
Etonogestrel—Oedema—Hydroxyurea—head and neck cancer	0.0035	0.00487	CcSEcCtD
Etonogestrel—Infection—Hydroxyurea—head and neck cancer	0.00347	0.00483	CcSEcCtD
Etonogestrel—Paraesthesia—Vinblastine—head and neck cancer	0.00344	0.00479	CcSEcCtD
Etonogestrel—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00343	0.00477	CcSEcCtD
Etonogestrel—Skin disorder—Hydroxyurea—head and neck cancer	0.0034	0.00473	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00339	0.012	CbGpPWpGaD
Etonogestrel—Breast disorder—Docetaxel—head and neck cancer	0.00334	0.00465	CcSEcCtD
Etonogestrel—Anorexia—Hydroxyurea—head and neck cancer	0.00333	0.00464	CcSEcCtD
Etonogestrel—Decreased appetite—Vinblastine—head and neck cancer	0.00333	0.00464	CcSEcCtD
Etonogestrel—Cramp muscle—Docetaxel—head and neck cancer	0.00333	0.00463	CcSEcCtD
Etonogestrel—Pain—Vinblastine—head and neck cancer	0.00328	0.00456	CcSEcCtD
Etonogestrel—Constipation—Vinblastine—head and neck cancer	0.00328	0.00456	CcSEcCtD
Etonogestrel—Feeling abnormal—Vinblastine—head and neck cancer	0.00316	0.0044	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00314	0.00436	CcSEcCtD
Etonogestrel—Alopecia—Fluorouracil—head and neck cancer	0.00313	0.00436	CcSEcCtD
Etonogestrel—Somnolence—Hydroxyurea—head and neck cancer	0.00311	0.00433	CcSEcCtD
Etonogestrel—Erythema—Fluorouracil—head and neck cancer	0.00308	0.00429	CcSEcCtD
Etonogestrel—Dyspepsia—Hydroxyurea—head and neck cancer	0.00308	0.00428	CcSEcCtD
Etonogestrel—Decreased appetite—Hydroxyurea—head and neck cancer	0.00304	0.00423	CcSEcCtD
Etonogestrel—Abdominal pain—Vinblastine—head and neck cancer	0.00303	0.00422	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00302	0.0042	CcSEcCtD
Etonogestrel—Fatigue—Hydroxyurea—head and neck cancer	0.00301	0.00419	CcSEcCtD
Etonogestrel—Constipation—Hydroxyurea—head and neck cancer	0.00299	0.00416	CcSEcCtD
Etonogestrel—Pain—Hydroxyurea—head and neck cancer	0.00299	0.00416	CcSEcCtD
Etonogestrel—Weight increased—Docetaxel—head and neck cancer	0.00291	0.00405	CcSEcCtD
Etonogestrel—Weight decreased—Docetaxel—head and neck cancer	0.00289	0.00402	CcSEcCtD
Etonogestrel—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00288	0.00401	CcSEcCtD
Etonogestrel—Infestation—Docetaxel—head and neck cancer	0.00285	0.00396	CcSEcCtD
Etonogestrel—Infestation NOS—Docetaxel—head and neck cancer	0.00285	0.00396	CcSEcCtD
Etonogestrel—Hypersensitivity—Vinblastine—head and neck cancer	0.00282	0.00393	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00279	0.00388	CcSEcCtD
Etonogestrel—Body temperature increased—Hydroxyurea—head and neck cancer	0.00276	0.00385	CcSEcCtD
Etonogestrel—Asthenia—Vinblastine—head and neck cancer	0.00275	0.00383	CcSEcCtD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00275	0.00976	CbGpPWpGaD
Etonogestrel—Convulsion—Fluorouracil—head and neck cancer	0.00267	0.00372	CcSEcCtD
Etonogestrel—Myalgia—Fluorouracil—head and neck cancer	0.00263	0.00365	CcSEcCtD
Etonogestrel—Diarrhoea—Vinblastine—head and neck cancer	0.00262	0.00365	CcSEcCtD
Etonogestrel—Discomfort—Fluorouracil—head and neck cancer	0.00259	0.00361	CcSEcCtD
Etonogestrel—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00258	0.00358	CcSEcCtD
Etonogestrel—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00257	0.00913	CbGpPWpGaD
Etonogestrel—Haemoglobin—Docetaxel—head and neck cancer	0.00257	0.00358	CcSEcCtD
Etonogestrel—Rhinitis—Docetaxel—head and neck cancer	0.00256	0.00357	CcSEcCtD
Etonogestrel—Haemorrhage—Docetaxel—head and neck cancer	0.00256	0.00356	CcSEcCtD
Etonogestrel—Hypoaesthesia—Docetaxel—head and neck cancer	0.00254	0.00354	CcSEcCtD
Etonogestrel—Pharyngitis—Docetaxel—head and neck cancer	0.00254	0.00353	CcSEcCtD
Etonogestrel—Dizziness—Vinblastine—head and neck cancer	0.00254	0.00353	CcSEcCtD
Etonogestrel—Urinary tract disorder—Docetaxel—head and neck cancer	0.00252	0.00351	CcSEcCtD
Etonogestrel—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00252	0.0035	CcSEcCtD
Etonogestrel—Oedema—Fluorouracil—head and neck cancer	0.00252	0.0035	CcSEcCtD
Etonogestrel—Connective tissue disorder—Docetaxel—head and neck cancer	0.00251	0.0035	CcSEcCtD
Etonogestrel—Asthenia—Hydroxyurea—head and neck cancer	0.00251	0.00349	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.00251	0.00891	CbGpPWpGaD
Etonogestrel—Urethral disorder—Docetaxel—head and neck cancer	0.00251	0.00349	CcSEcCtD
Etonogestrel—Infection—Fluorouracil—head and neck cancer	0.0025	0.00348	CcSEcCtD
Etonogestrel—ESR1—Estrogen signaling pathway—MAPK1—head and neck cancer	0.00249	0.00884	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.00248	0.0088	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Fluorouracil—head and neck cancer	0.00247	0.00343	CcSEcCtD
Etonogestrel—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00247	0.00877	CbGpPWpGaD
Etonogestrel—Visual impairment—Docetaxel—head and neck cancer	0.00246	0.00343	CcSEcCtD
Etonogestrel—Vomiting—Vinblastine—head and neck cancer	0.00244	0.00339	CcSEcCtD
Etonogestrel—Headache—Vinblastine—head and neck cancer	0.0024	0.00334	CcSEcCtD
Etonogestrel—Anorexia—Fluorouracil—head and neck cancer	0.0024	0.00334	CcSEcCtD
Etonogestrel—Diarrhoea—Hydroxyurea—head and neck cancer	0.00239	0.00333	CcSEcCtD
Etonogestrel—Eye disorder—Docetaxel—head and neck cancer	0.00239	0.00332	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.00238	0.00846	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00234	0.00831	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00233	0.00827	CbGpPWpGaD
Etonogestrel—Angiopathy—Docetaxel—head and neck cancer	0.00232	0.00323	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.00231	0.00822	CbGpPWpGaD
Etonogestrel—Dizziness—Hydroxyurea—head and neck cancer	0.00231	0.00322	CcSEcCtD
Etonogestrel—Immune system disorder—Docetaxel—head and neck cancer	0.00231	0.00321	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00229	0.00319	CcSEcCtD
Etonogestrel—Nausea—Vinblastine—head and neck cancer	0.00228	0.00317	CcSEcCtD
Etonogestrel—Insomnia—Fluorouracil—head and neck cancer	0.00228	0.00317	CcSEcCtD
Etonogestrel—Paraesthesia—Fluorouracil—head and neck cancer	0.00226	0.00314	CcSEcCtD
Etonogestrel—Alopecia—Docetaxel—head and neck cancer	0.00226	0.00314	CcSEcCtD
Etonogestrel—Mental disorder—Docetaxel—head and neck cancer	0.00224	0.00312	CcSEcCtD
Etonogestrel—Somnolence—Fluorouracil—head and neck cancer	0.00224	0.00311	CcSEcCtD
Etonogestrel—Erythema—Docetaxel—head and neck cancer	0.00223	0.0031	CcSEcCtD
Etonogestrel—Malnutrition—Docetaxel—head and neck cancer	0.00223	0.0031	CcSEcCtD
Etonogestrel—Vomiting—Hydroxyurea—head and neck cancer	0.00222	0.00309	CcSEcCtD
Etonogestrel—Dyspepsia—Fluorouracil—head and neck cancer	0.00222	0.00308	CcSEcCtD
Etonogestrel—Rash—Hydroxyurea—head and neck cancer	0.0022	0.00307	CcSEcCtD
Etonogestrel—Dermatitis—Hydroxyurea—head and neck cancer	0.0022	0.00306	CcSEcCtD
Etonogestrel—Headache—Hydroxyurea—head and neck cancer	0.00219	0.00305	CcSEcCtD
Etonogestrel—Decreased appetite—Fluorouracil—head and neck cancer	0.00219	0.00304	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00217	0.00302	CcSEcCtD
Etonogestrel—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.00216	0.00767	CbGpPWpGaD
Etonogestrel—Back pain—Docetaxel—head and neck cancer	0.00215	0.003	CcSEcCtD
Etonogestrel—Pain—Fluorouracil—head and neck cancer	0.00215	0.00299	CcSEcCtD
Etonogestrel—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00215	0.00764	CbGpPWpGaD
Etonogestrel—Muscle spasms—Docetaxel—head and neck cancer	0.00214	0.00298	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00212	0.00753	CbGpPWpGaD
Etonogestrel—Nausea—Hydroxyurea—head and neck cancer	0.00208	0.00289	CcSEcCtD
Etonogestrel—Feeling abnormal—Fluorouracil—head and neck cancer	0.00207	0.00289	CcSEcCtD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00207	0.00735	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.00204	0.00727	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.00201	0.00716	CbGpPWpGaD
Etonogestrel—Urticaria—Fluorouracil—head and neck cancer	0.002	0.00278	CcSEcCtD
Etonogestrel—Body temperature increased—Fluorouracil—head and neck cancer	0.00199	0.00277	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.00196	0.00696	CbGpPWpGaD
Etonogestrel—Cough—Docetaxel—head and neck cancer	0.00194	0.0027	CcSEcCtD
Etonogestrel—Convulsion—Docetaxel—head and neck cancer	0.00193	0.00268	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00193	0.00685	CbGpPWpGaD
Etonogestrel—Hypertension—Docetaxel—head and neck cancer	0.00192	0.00267	CcSEcCtD
Etonogestrel—Myalgia—Docetaxel—head and neck cancer	0.00189	0.00264	CcSEcCtD
Etonogestrel—Arthralgia—Docetaxel—head and neck cancer	0.00189	0.00264	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00188	0.00262	CcSEcCtD
Etonogestrel—Hypersensitivity—Fluorouracil—head and neck cancer	0.00185	0.00258	CcSEcCtD
Etonogestrel—Anaphylactic shock—Docetaxel—head and neck cancer	0.00182	0.00253	CcSEcCtD
Etonogestrel—Oedema—Docetaxel—head and neck cancer	0.00182	0.00253	CcSEcCtD
Etonogestrel—Infection—Docetaxel—head and neck cancer	0.0018	0.00251	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.00179	0.00637	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Docetaxel—head and neck cancer	0.00178	0.00248	CcSEcCtD
Etonogestrel—Pruritus—Fluorouracil—head and neck cancer	0.00178	0.00248	CcSEcCtD
Etonogestrel—Skin disorder—Docetaxel—head and neck cancer	0.00176	0.00246	CcSEcCtD
Etonogestrel—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.00176	0.00626	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.00174	0.00618	CbGpPWpGaD
Etonogestrel—Anorexia—Docetaxel—head and neck cancer	0.00173	0.00241	CcSEcCtD
Etonogestrel—Diarrhoea—Fluorouracil—head and neck cancer	0.00172	0.0024	CcSEcCtD
Etonogestrel—Dizziness—Fluorouracil—head and neck cancer	0.00166	0.00232	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00165	0.0023	CcSEcCtD
Etonogestrel—Insomnia—Docetaxel—head and neck cancer	0.00164	0.00229	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00163	0.0058	CbGpPWpGaD
Etonogestrel—Paraesthesia—Docetaxel—head and neck cancer	0.00163	0.00227	CcSEcCtD
Etonogestrel—Somnolence—Docetaxel—head and neck cancer	0.00161	0.00225	CcSEcCtD
Etonogestrel—Vomiting—Fluorouracil—head and neck cancer	0.0016	0.00223	CcSEcCtD
Etonogestrel—Dyspepsia—Docetaxel—head and neck cancer	0.0016	0.00223	CcSEcCtD
Etonogestrel—Rash—Fluorouracil—head and neck cancer	0.00159	0.00221	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.00159	0.00564	CbGpPWpGaD
Etonogestrel—Dermatitis—Fluorouracil—head and neck cancer	0.00159	0.00221	CcSEcCtD
Etonogestrel—Decreased appetite—Docetaxel—head and neck cancer	0.00158	0.0022	CcSEcCtD
Etonogestrel—Headache—Fluorouracil—head and neck cancer	0.00158	0.00219	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00157	0.00218	CcSEcCtD
Etonogestrel—Fatigue—Docetaxel—head and neck cancer	0.00157	0.00218	CcSEcCtD
Etonogestrel—Constipation—Docetaxel—head and neck cancer	0.00155	0.00216	CcSEcCtD
Etonogestrel—Pain—Docetaxel—head and neck cancer	0.00155	0.00216	CcSEcCtD
Etonogestrel—Feeling abnormal—Docetaxel—head and neck cancer	0.0015	0.00208	CcSEcCtD
Etonogestrel—Nausea—Fluorouracil—head and neck cancer	0.00149	0.00208	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00149	0.0053	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.00149	0.0053	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00149	0.00207	CcSEcCtD
Etonogestrel—Abdominal pain—Docetaxel—head and neck cancer	0.00144	0.002	CcSEcCtD
Etonogestrel—Body temperature increased—Docetaxel—head and neck cancer	0.00144	0.002	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00143	0.00508	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00143	0.00507	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.0014	0.00497	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.00137	0.00485	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00136	0.00483	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Docetaxel—head and neck cancer	0.00134	0.00186	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.00133	0.00474	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.00133	0.00473	CbGpPWpGaD
Etonogestrel—Asthenia—Docetaxel—head and neck cancer	0.0013	0.00181	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.0013	0.00462	CbGpPWpGaD
Etonogestrel—Pruritus—Docetaxel—head and neck cancer	0.00129	0.00179	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.00127	0.0045	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.00126	0.00447	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.00126	0.00446	CbGpPWpGaD
Etonogestrel—Diarrhoea—Docetaxel—head and neck cancer	0.00124	0.00173	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.00123	0.00437	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.00123	0.00437	CbGpPWpGaD
Etonogestrel—Dizziness—Docetaxel—head and neck cancer	0.0012	0.00167	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.00117	0.00416	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00116	0.00411	CbGpPWpGaD
Etonogestrel—Vomiting—Docetaxel—head and neck cancer	0.00115	0.00161	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.00115	0.00409	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.00115	0.00407	CbGpPWpGaD
Etonogestrel—Rash—Docetaxel—head and neck cancer	0.00115	0.00159	CcSEcCtD
Etonogestrel—Dermatitis—Docetaxel—head and neck cancer	0.00114	0.00159	CcSEcCtD
Etonogestrel—Headache—Docetaxel—head and neck cancer	0.00114	0.00158	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.00111	0.00394	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.0011	0.00392	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.0011	0.0039	CbGpPWpGaD
Etonogestrel—Nausea—Docetaxel—head and neck cancer	0.00108	0.0015	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.00106	0.00378	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.00105	0.00374	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.00104	0.00371	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.00104	0.00371	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.00102	0.00361	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000983	0.00349	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000966	0.00343	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000957	0.0034	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000955	0.00339	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000943	0.00335	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000935	0.00332	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000935	0.00332	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000893	0.00317	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000881	0.00313	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—RARB—head and neck cancer	0.000863	0.00307	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000857	0.00305	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000821	0.00292	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000819	0.00291	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000812	0.00288	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00081	0.00288	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000791	0.00281	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—YAP1—head and neck cancer	0.000785	0.00279	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000775	0.00276	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.000751	0.00267	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000741	0.00263	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000735	0.00261	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000724	0.00257	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KISS1—head and neck cancer	0.000722	0.00256	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000703	0.0025	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000685	0.00243	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000679	0.00241	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000679	0.00241	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000675	0.0024	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.000663	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000645	0.00229	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000644	0.00229	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000613	0.00218	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GRP—head and neck cancer	0.000594	0.00211	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000583	0.00207	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT6—head and neck cancer	0.000577	0.00205	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000577	0.00205	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000562	0.002	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000552	0.00196	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000552	0.00196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000549	0.00195	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000549	0.00195	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—YAP1—head and neck cancer	0.000511	0.00181	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000508	0.00181	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—RARB—head and neck cancer	0.000507	0.0018	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000481	0.00171	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000476	0.00169	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000463	0.00165	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—YAP1—head and neck cancer	0.000461	0.00164	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000457	0.00163	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000457	0.00162	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.000441	0.00157	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000431	0.00153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.000424	0.00151	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000405	0.00144	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.0004	0.00142	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000397	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000391	0.00139	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.000389	0.00138	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000384	0.00137	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000384	0.00136	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000379	0.00135	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH1—head and neck cancer	0.000354	0.00126	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000349	0.00124	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000339	0.0012	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UROD—head and neck cancer	0.000338	0.0012	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000324	0.00115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.0003	0.00107	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH1—head and neck cancer	0.00023	0.000818	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.000208	0.000738	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK3—head and neck cancer	0.000196	0.000696	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—head and neck cancer	0.000158	0.000563	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—head and neck cancer	0.000154	0.000549	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—head and neck cancer	0.000149	0.00053	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAT2—head and neck cancer	0.00014	0.000499	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000135	0.00048	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—head and neck cancer	0.000135	0.000478	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—head and neck cancer	0.000133	0.000474	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—head and neck cancer	0.000132	0.000469	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK3—head and neck cancer	0.000127	0.000453	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—DPYD—head and neck cancer	0.000123	0.000438	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK1—head and neck cancer	0.000121	0.000431	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—head and neck cancer	0.000121	0.00043	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—YAP1—head and neck cancer	0.000117	0.000415	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK3—head and neck cancer	0.000115	0.000408	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—head and neck cancer	0.000105	0.000374	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—head and neck cancer	0.000102	0.000361	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—head and neck cancer	9.73e-05	0.000346	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—head and neck cancer	9.29e-05	0.00033	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—head and neck cancer	9.06e-05	0.000322	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—head and neck cancer	8.75e-05	0.000311	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—head and neck cancer	8.59e-05	0.000305	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—head and neck cancer	7.9e-05	0.000281	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—head and neck cancer	7.82e-05	0.000278	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—head and neck cancer	7.75e-05	0.000276	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK3—head and neck cancer	7.47e-05	0.000266	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK1—head and neck cancer	7.11e-05	0.000253	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—head and neck cancer	7.11e-05	0.000253	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMS—head and neck cancer	7.02e-05	0.000249	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.93e-05	0.000246	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPX1—head and neck cancer	6.64e-05	0.000236	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.57e-05	0.000234	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	6.17e-05	0.000219	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—head and neck cancer	5.97e-05	0.000212	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—head and neck cancer	5.71e-05	0.000203	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—head and neck cancer	5.04e-05	0.000179	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.91e-05	0.000139	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—head and neck cancer	3.41e-05	0.000121	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.41e-05	8.55e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—head and neck cancer	1.96e-05	6.98e-05	CbGpPWpGaD
